Skip to main content
Medical information Clinical review pending

Immunology Testing

Immunohistochemistry Polyoma BK Virus SV 40 Test

This test detects the Polyoma BK virus in kidney tissue samples using immunohistochemistry. It is important for diagnosing kidney disorders, especially in transplant patients.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tumor tissue in 10% formal-saline or formalin-fixed paraffin-embedded blocks.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. Provide a copy of the histopathology report, the site of biopsy, and relevant clinical history with the sample.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry Polyoma BK Virus SV 40 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Patients with a history of kidney transplants
  • ✓Individuals experiencing symptoms of kidney dysfunction
  • ✓Patients with risk factors for kidney disease
  • ✓Evaluation of kidney tissue for viral presence
  • ✓Monitoring post-transplant complications
02

In plain language

What this test helps you understand

Detects the presence of Polyoma BK virus in kidney tissue, aiding in the diagnosis and management of kidney disorders, particularly in transplant recipients.
The Immunohistochemistry Polyoma BK Virus SV 40 Test is a specialized diagnostic tool used to detect the presence of the Polyoma BK virus in kidney tissues. This test is particularly important for patients who have undergone kidney transplants or have underlying kidney disorders, as the virus can lead to serious complications if not identified and managed promptly.

This test measures the presence of the Polyoma BK virus in tumor tissue samples. By utilizing immunohistochemistry techniques, the test identifies viral antigens in the tissue, providing crucial information about the viral load and its potential impact on kidney function.

Results from the Immunohistochemistry Polyoma BK Virus SV 40 Test will be interpreted by qualified healthcare professionals. Generally, a positive result indicates the presence of the virus, which may necessitate further evaluation and management strategies. A negative result suggests that the virus is not present in the tissue sample.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Provide a copy of the histopathology report, the site of biopsy, and relevant clinical history with the sample.
SampleTumor tissue in 10% formal-saline or formalin-fixed paraffin-embedded blocks.
MethodologyImmunohistochemistry (IHC) technique used to identify viral antigens in tissue.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the virus in the provided tissue sample only. It does not provide information about the overall viral load in the body or predict future complications.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Polyoma BK virus is a common virus that can reactivate in individuals with weakened immune systems, such as kidney transplant recipients, potentially causing kidney problems.
The virus can cause significant kidney damage (polyomavirus-associated nephropathy) in transplant patients. Early detection allows for timely management to protect the transplanted kidney.
A tissue sample from the kidney, typically obtained through a biopsy, is required. The sample should be formalin-fixed and paraffin-embedded or in formalin-saline.
A pathologist or qualified healthcare provider will interpret the results. A positive result indicates the presence of the virus in the tissue sample.
Your doctor will discuss the results with you and determine the appropriate next steps, which may include further tests or treatment adjustments.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp